-
- Contract/Tender
- Posted 2 years ago
Request for Information (RFI): Priorities for Cancer Control and Population Sciences at NCI
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Correction to PAR-21-237 "NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NCI Participation in NOT-OD-22-030, "Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Change to Eligibility Information in RFA-AI-21-079, Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
at National Institutes of Health in United States -
- Fellowship
- Posted 2 years ago
Notice of Intent to Publish a Funding Opportunity Announcement for Learning Disabilities Research Centers (P50 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Correction to Eligibility Information in RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Clarification of Eligibility Regarding Foreign Components for PAR-20-084, "NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Correction to Specific Areas of Research Interest of Participating Institutes and Centers In RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
NIGMS Limitations on Clinical Trial Applications Submitted to the NIH Research Project Grant (Parent R01 Clinical Trial Required)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NIAAA's Participation in PAR-21-358, Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Change to RFA-CA-22-001, "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Special Interest: Neuro-Glia Mechanisms Governing Complex Behaviors (R01 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NCI Participation in PAR-22-064, "Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NINDS Participation in RFA-MD-22-004 "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)".
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Correction for PAR-22-081 Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Correction for PAR-22-091, "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Contract/Tender
- Posted 2 years ago
Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Change to RFA-CA-22-003, "Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Correction for PAR-22-088 Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
at National Institutes of Health in United States -
- Fellowship
- Posted 2 years ago
Notice of Intent to Publish a Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional)
at National Institutes of Health in United States -
- Fellowship
- Posted 2 years ago
Request for Information (RFI) on Advancing Research in Fundamental Neuroscience
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)
at National Institutes of Health in United States